rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Linda A. Hill

Director

Company insider

Files Form 4 as: Director, Relay Therapeutics; Director, State Street; Director, Eaton Corporation; Director, Cooper Industries.

In numbers

Trades disclosed
69
Buys
0
Sells
4
Bought
$0
Sold
$816K
Companies
4
Companies where not an officer
4
First trade
25 Apr 2005
Last trade
9 Jun 2026
Last filed
10 Jun 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
RLAY Relay TherapeuticsDirector · Biotechnology · last 9 Jun 20260 buys · 0 sells
STT State StreetDirector · Capital Markets & Asset Management · last 16 May 20180 buys · 0 sells
ETN Eaton CorporationDirector · Machinery · last 21 Feb 20170 buys · 0 sells
Cooper IndustriesDirector · last 30 Nov 20120 buys · 4 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
9 Jun 2026filed 10 Jun 2026RLAY Relay Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—32,947 at $0.00filing
9 Jun 2026filed 10 Jun 2026RLAY Relay Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—32,947 at $0.00filing
6 Jun 2025filed 6 Jun 2025RLAY Relay Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—136,681 at $0.00filing
3 Jun 2024filed 5 Jun 2024RLAY Relay Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—102,225 at $0.00filing
31 May 2023filed 1 Jun 2023RLAY Relay Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—66,055 at $0.00filing
27 May 2022filed 27 May 2022RLAY Relay Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—41,597 at $0.00filing
19 May 2021filed 21 May 2021RLAY Relay Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—16,000 at $0.00filing
16 May 2018filed 18 May 2018STT State StreetCapital Markets & Asset ManagementSEC FORM 4 Code A—1,929 at $0.00filing
17 May 2017filed 19 May 2017STT State StreetCapital Markets & Asset ManagementSEC FORM 4 Code A—1,880 at $0.00filing
21 Feb 2017filed 23 Feb 2017ETN Eaton Corporationoption or derivative · MachinerySEC FORM 4 Code A—2,100 at $0.00filing
18 May 2016filed 20 May 2016STT State StreetCapital Markets & Asset ManagementSEC FORM 4 Code A—2,440 at $0.00filing
23 Feb 2016filed 25 Feb 2016ETN Eaton Corporationoption or derivative · MachinerySEC FORM 4 Code A—2,615 at $0.00filing
20 May 2015filed 21 May 2015STT State StreetCapital Markets & Asset ManagementSEC FORM 4 Code A—1,900 at $0.00filing
28 Jan 2015filed 2 Feb 2015ETN Eaton Corporationoption or derivative · MachinerySEC FORM 4 Code A—2,170 at $0.00filing
14 May 2014filed 16 May 2014STT State StreetCapital Markets & Asset ManagementSEC FORM 4 Code A—2,159 at $0.00filing
22 Jan 2014filed 24 Jan 2014ETN Eaton Corporationoption or derivative · MachinerySEC FORM 4 Code A—1,724 at $0.00filing
15 May 2013filed 16 May 2013STT State StreetCapital Markets & Asset ManagementSEC FORM 4 Code A—2,044 at $0.00filing
23 Jan 2013filed 25 Jan 2013ETN Eaton Corporationoption or derivative · MachinerySEC FORM 4 Code A—2,338 at $0.00filing
30 Nov 2012filed 4 Dec 2012Cooper Industriesoption or derivativeSEC FORM 4 Code D$202K4,000 at $50.46filing
30 Nov 2012filed 4 Dec 2012Cooper Industriesoption or derivativeSEC FORM 4 Code D$186K4,000 at $46.50filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Not placed4

Buys in green, sells in red, by the company’s sector.

Related people

Sanjiv PatelPresident and CEO · President and CEO at Relay Therapeutics, filing Form 4 there in the last year
Thomas CatinazzoChief Financial Officer · Chief Financial Officer at Relay Therapeutics, filing Form 4 there in the last year
Donald A. BergstromPresident, R&D · President, R&D at Relay Therapeutics, filing Form 4 there in the last year
SVF Pauling (Cayman) Ltd10% owner · 10% owner at Relay Therapeutics, filing Form 4 there in the last year
Peter RahmerOfficer · Insider at Relay Therapeutics, filing Form 4 there in the last year